AMAG submits ferumoxytol NDA

AMAG submitted an NDA to FDA for ferumoxytol, an IV iron replacement therapeutic, to treat anemia in patients with chronic kidney disease (CKD). On Wednesday, AMAG was up $0.10 to $60.65. ...